GlassScriptPhysician profile
Sierra Mckee
NPI 1053186346
$385.98
in general payments reported to CMS, 2019-2025
12 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $60.51 | 2025 | Itind System |
| Janssen Biotech, INC. | $54.52 | 2025 | Erleada |
| Ferring Pharmaceuticals INC. | $51.67 | 2025 | Adstiladrin |
| Cumberland Pharmaceuticals, INC. | $41.69 | 2025 | Caldolor |
| Pfizer INC. | $37.85 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.37 | 2025 | |
| Procept Biorobotics Corporation | $21.60 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $21.32 | 2025 | |
| Astellas Pharma US INC | $21.16 | 2025 | Padcev |
| Sumitomo Pharma America, INC. | $18.04 | 2025 | Orgovyx |
| Merck Sharp & Dohme LLC | $17.99 | 2025 | Keytruda |
| Urogen Pharma, INC. | $15.26 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sierra Mckee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.